色剂和头癌:一个系统的审查和元分析
Neil P Monaghan1,2, Kelsey A Duckett1,2, Shaun A Nguyen1
1Department of Otolaryngology-Head and Neck Surgery Medical University of South Carolina Charleston South Carolina USA.
World journal of otorhinolaryngology - head and neck surgery
|March 12, 2025
概括
暴露于色剂的人群中,头癌更为普遍. 这一系统性审查发现,与未暴露的对照人群相比,暴露于色剂的人群中头癌的发病率和死亡率更高.
科学领域:
- 环境健康 环境健康
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 色剂暴露与各种健康问题有关.
- 了解与剂相关的特定癌症风险对于公共卫生至关重要.
- 头部和部癌症代表了一大批恶性瘤.
研究的目的:
- 评估暴露于色剂的人群中头癌的发病率和死亡率.
- 为了比较暴露于色剂的人群和未暴露的对照组之间的癌症率.
主要方法:
- 在2023年4月之前,对通过CINAHL,PubMed和Scopus识别的研究进行系统审查.
- 纳入标准集中在报告头癌发病率或死亡率的研究中,这些研究的参与者暴露于色剂.
- 用比例的元分析计算和比较发病率和死亡率.
主要成果:
- 综述包括了13项研究,分析了来自1530个独特摘要的数据.
- 暴露于色剂的人群中,头癌更常见 (差异为0.061%,p < 0.0001).
- 口腔和喉是暴露患者中最常见的亚部位;口腔和喉是暴露患者中死亡最常见的亚部位.
结论:
- 研究结果表明,暴露于色剂的人群中,头癌的发病率显著增加.
- 色剂暴露与头癌死亡的可能性增加有关.
- 由于研究的局限性,建议进行进一步的研究,以探索子站点特定的结果.
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Hazard Ratio
73
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
73
Cancer Survival Analysis
318
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
318
Types of Toxins
1.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


